 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1404 | 回復: 8 | |||
| 當前只顯示滿足指定條件的回帖，點擊這里查看本話題的所有回帖 | |||
lg123456木蟲 (正式寫手)
|
[求助]
Doxorubicin hydrochloride原料2019版日本藥典標準 已有1人參與
|
||
各位老師，求助Doxorubicin hydrochloride原料2019版日本藥典標準。萬分謝謝 |
回復此樓» 猜你喜歡
腫瘤代謝免疫與臨床藥理等方向接收優(yōu)質(zhì)調(diào)劑生
已經(jīng)有0人回復
-
藥學考研調(diào)劑
已經(jīng)有0人回復
-
藥理學論文潤色/翻譯怎么收費?
已經(jīng)有208人回復
-
華南理工大學-醫(yī)學院-藥學專碩少量調(diào)劑名額
已經(jīng)有28人回復
-
求助《生物利用度和生物等效性研究指導原則》（試 行），2002
已經(jīng)有0人回復
-
文獻求助
已經(jīng)有0人回復
-
關于SCI雜志發(fā)表掛名
已經(jīng)有32人回復
1949stone
榮譽版主 (知名作家)
海納百川
- 應助: 95 (初中生)
- 貴賓: 2.38
- 金幣: 2622.9
- 散金: 3394
- 紅花: 177
- 沙發(fā): 8
- 帖子: 9829
- 在線: 2692.8小時
- 蟲號: 765987
- 注冊: 2009-05-08
- 性別: GG
- 專業(yè): 藥物分析
- 管轄: 分子生物
【答案】應助回帖
|
Japanese Pharmacopoeia Japanese Pharmacopoeia (JP) is established and published to regulate the properties and quality of drugs by the Minister of Health, Labour and Welfare after hearing the opinion of the Pharmaceutical Affairs and Food Sanitation Council (PAFSC). The JP consists of General Notices, General Rules for Crude Drugs, General Rules for Preparations, General Tests, Processes and Apparatus and Official Monographs. Items selected for entry in the JP must be those important in health care based on the necessity of the drug in medical practice, wide application and experience of use. Since it was first published in June 1886, the JP has been revised many times periodically. The 17th edition of the JP came into effect on April 1, 2016. The Japanese Pharmacopoeia 17th edition PDF The Japanese Pharmacopoeia 17th edition（March 7, 2016 The MHLW Ministerial Notification No. 64）[100,000KB] PDF Table of errata[459KB] PDF Supplement I of the 17th edition(December 1, 2017 The MHLW Ministerial Notification No.348)[4,725KB] Supplement Ⅱ of the 17th edition(June 28, 2019 The MHLW Ministerial Notification No.49)[This document is currently under construction.] |
3樓2019-08-10 17:41:08
1949stone
榮譽版主 (知名作家)
海納百川
- 應助: 95 (初中生)
- 貴賓: 2.38
- 金幣: 2622.9
- 散金: 3394
- 紅花: 177
- 沙發(fā): 8
- 帖子: 9829
- 在線: 2692.8小時
- 蟲號: 765987
- 注冊: 2009-05-08
- 性別: GG
- 專業(yè): 藥物分析
- 管轄: 分子生物
2樓2019-08-10 17:35:18
1949stone
榮譽版主 (知名作家)
海納百川
- 應助: 95 (初中生)
- 貴賓: 2.38
- 金幣: 2622.9
- 散金: 3394
- 紅花: 177
- 沙發(fā): 8
- 帖子: 9829
- 在線: 2692.8小時
- 蟲號: 765987
- 注冊: 2009-05-08
- 性別: GG
- 專業(yè): 藥物分析
- 管轄: 分子生物
【答案】應助回帖
|
Japanese Pharmacopoeia |
» 本帖附件資源列表
-
歡迎監(jiān)督和反饋：小木蟲僅提供交流平臺，不對該內(nèi)容負責。
本內(nèi)容由用戶自主發(fā)布，如果其內(nèi)容涉及到知識產(chǎn)權(quán)問題，其責任在于用戶本人，如對版權(quán)有異議，請聯(lián)系郵箱：xiaomuchong@tal.com - 附件 1 : 導出頁面自_Japanese_Pharmacopoeia_17th_Edition_wrapper.pdf
2019-08-10 17:51:09, 801.65 K
4樓2019-08-10 17:51:14
lg123456
木蟲 (正式寫手)
- 應助: 7 (幼兒園)
- 金幣: 3942.6
- 散金: 542
- 紅花: 3
- 帖子: 626
- 在線: 384小時
- 蟲號: 1387474
- 注冊: 2011-09-02
- 性別: GG
- 專業(yè): 藥物分析
6樓2019-08-14 19:07:25
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料與化工，291分，求調(diào)劑 +8 | 咕嚕咕嚕123123 2026-03-04 | 10/500 |
|
|---|---|---|---|---|
|
|
[考研] 085600材料調(diào)劑 總分330 +4 | 池池丶 2026-03-03 | 4/200 |
|
|
[考研] 264求調(diào)劑 +8 | 26調(diào)劑 2026-03-03 | 8/400 |
|
|
|
[考研] 學碩材料275調(diào)劑 +9 | 路三三 2026-03-03 | 9/450 |
|
|
|
[考研] 295求調(diào)劑 +6 | 等春來， 2026-03-04 | 6/300 |
|
|
|
[論文投稿]
 主編終審卡者不動
 100+3
|
Stray2021 2026-03-03 | 3/150 |
|
|
|
[考研] 325求調(diào)劑 +5 | 學家科 2026-03-04 | 5/250 |
|
|
|
[考研]
0703化學學碩 288分
+4
|
旅行中的紫葡萄 2026-03-03 | 4/200 |
|
|
|
[考研] 0856材料工程，初試313調(diào)劑 +7 | 賣個關子吧 2026-03-03 | 7/350 |
|
|
|
[考研] 材料學碩318求調(diào)劑 +15 | February_Feb 2026-03-01 | 17/850 |
|
|
|
[考研] 求調(diào)劑 +4 | Guo_yuxuan 2026-03-02 | 5/250 |
|
|
|
[考研] 299求調(diào)劑 +5 | kkcoco25 2026-03-02 | 9/450 |
|
|
|
[考研] 求調(diào)劑 +11 | yunziaaaaa 2026-03-01 | 13/650 |
|
|
|
[考研] 306分材料調(diào)劑 +5 | chuanzhu川燭 2026-03-01 | 6/300 |
|
|
|
[考研] 275求調(diào)劑 +7 | 明遠求學 2026-03-01 | 7/350 |
|
|
|
[考研] 一志愿中石油（華東）本科齊魯工業(yè)大學 +3 | 石能偉 2026-03-02 | 3/150 |
|
|
|
[考研] 材料調(diào)劑 +3 | 恒順自然 2026-03-02 | 3/150 |
|
|
|
[考博] 誠招農(nóng)業(yè)博士 +3 | 心欣向榮 2026-02-28 | 3/150 |
|
|
|
[考研] 材料學調(diào)劑 +10 | 提神豆沙包 2026-02-28 | 12/600 |
|
|
|
[考研] 化工299分求調(diào)劑 一志愿985落榜 +5 | 嘻嘻(*^ω^*) 2026-03-01 | 5/250 |
|